84 related articles for article (PubMed ID: 2627497)
21. The carboxyl group in the active center of transketolase.
Meshalkina LE; Kuimov AN; Kabakov AN; Tsorina ON; Kochetov GA
Biochem Int; 1984 Jul; 9(1):9-16. PubMed ID: 6477641
[TBL] [Abstract][Full Text] [Related]
22. Characterization and clinical study on the acellular pertussis vaccine produced by a combination of column purified pertussis toxin and filamentous hemagglutinin.
Ginnaga A; Morokuma K; Aihara K; Sakou M; Imaizumi A; Suzuki Y; Sato H; Sato Y; Ueda K; Kuno-Sakai H
Tokai J Exp Clin Med; 1988; 13 Suppl():59-69. PubMed ID: 2908528
[TBL] [Abstract][Full Text] [Related]
23. Inactivation of bovine thrombin by water-soluble carbodiimides: the essential carboxyl group has a pKa of 5.51.
Chan VW; Jorgensen AM; Borders CL
Biochem Biophys Res Commun; 1988 Mar; 151(2):709-16. PubMed ID: 3348805
[TBL] [Abstract][Full Text] [Related]
24. Acellular vaccines induce cell-mediated immunity to Bordetella pertussis antigens in infants undergoing primary vaccination against pertussis.
Ausiello CM; Urbani F; La Sala A; Lande R; Piscitelli A; Cassone A
Dev Biol Stand; 1997; 89():315-20. PubMed ID: 9272365
[TBL] [Abstract][Full Text] [Related]
25. Dose-response to a two-component acellular pertussis vaccine in infants and comparison with whole-cell vaccine.
Auerbach BS; Lake AM; Wilson ME; Willingham FF; Shematek J; Moulton L; Deforest A; Halsey NA
Biologicals; 1998 Jun; 26(2):145-53. PubMed ID: 9811522
[TBL] [Abstract][Full Text] [Related]
26. Production and purification of Bordetella pertussis toxin.
Ju CL; Sheu GC; Cheng Y; Lu CH
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1997 May; 30(2):72-83. PubMed ID: 10592813
[TBL] [Abstract][Full Text] [Related]
27. Construction and characterization of genetically inactivated pertussis toxin.
Brown DR; Keith JM; Sato H; Sato Y
Dev Biol Stand; 1991; 73():63-73. PubMed ID: 1778335
[TBL] [Abstract][Full Text] [Related]
28. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group.
Greco D; Salmaso S; Mastrantonio P; Giuliano M; Tozzi AE; Anemona A; Ciofi degli Atti ML; Giammanco A; Panei P; Blackwelder WC; Klein DL; Wassilak SG
N Engl J Med; 1996 Feb; 334(6):341-8. PubMed ID: 8538704
[TBL] [Abstract][Full Text] [Related]
29. ADP-ribosylation activity in pertussis vaccines and its relationship to the in vivo histamine-sensitisation test.
Gomez SR; Yuen CT; Asokanathan C; Douglas-Bardsley A; Corbel MJ; Coote JG; Parton R; Xing DK
Vaccine; 2007 Apr; 25(17):3311-8. PubMed ID: 17287049
[TBL] [Abstract][Full Text] [Related]
30. Assessment of safety and efficacy against Bordetella pertussis of a new tetanus-reduced dose diphtheria-acellular pertussis vaccine in a murine model.
Kwon HJ; Han SB; Kim BR; Kang KR; Huh DH; Choi GS; Ahn DH; Kang JH
BMC Infect Dis; 2017 Apr; 17(1):247. PubMed ID: 28376777
[TBL] [Abstract][Full Text] [Related]
31. Protective activity of the Bordetella pertussis BrkA autotransporter in the murine lung colonization model.
Marr N; Oliver DC; Laurent V; Poolman J; Denoël P; Fernandez RC
Vaccine; 2008 Aug; 26(34):4306-11. PubMed ID: 18582518
[TBL] [Abstract][Full Text] [Related]
32. Inactivation of human thrombin by water-soluble carbodiimides. The essential carboxyl has a pKa of 5.6 and is one other than Asp-189.
Borders CL; Chan VW; Miner LA; Weerasuriya YM
FEBS Lett; 1989 Sep; 255(2):365-8. PubMed ID: 2792382
[TBL] [Abstract][Full Text] [Related]
33. Comparison of 13 acellular pertussis vaccines: overview and serologic response.
Edwards KM; Meade BD; Decker MD; Reed GF; Rennels MB; Steinhoff MC; Anderson EL; Englund JA; Pichichero ME; Deloria MA
Pediatrics; 1995 Sep; 96(3 Pt 2):548-57. PubMed ID: 7659475
[TBL] [Abstract][Full Text] [Related]
34. Engineering bacterial toxin for the development of new vaccine against pertussis.
Bartoloni A; Pizza M; Gross R; Perugini M; Arico B; Domenighini M; Rappuoli R
Tokai J Exp Clin Med; 1988; 13 Suppl():217-22. PubMed ID: 2483870
[TBL] [Abstract][Full Text] [Related]
35. Protective immunogenicity of synthetic peptides selected from the amino acid sequence of Bordetella pertussis toxin subunit S1.
Askelöf P; Rodmalm K; Wrangsell G; Larsson U; Svenson SB; Cowell JL; Undén A; Bartfai T
Dev Biol Stand; 1991; 73():111-20. PubMed ID: 1778305
[TBL] [Abstract][Full Text] [Related]
36. The reaction of bacterial toxins with formaldehyde and its use for antigen stabilization.
Petre J; Pizza M; Nencioni L; Podda A; De Magistris MT; Rappuoli R
Dev Biol Stand; 1996; 87():125-34. PubMed ID: 8854009
[TBL] [Abstract][Full Text] [Related]
37. Antibody coating of liposomes with 1-ethyl-3-(3-dimethyl-aminopropyl)carbodiimide and the effect on target specificity.
Endoh H; Suzuki Y; Hashimoto Y
J Immunol Methods; 1981; 44(1):79-85. PubMed ID: 7252176
[TBL] [Abstract][Full Text] [Related]
38. Mepyramine but not cimetidine or clobenpropit blocks pertussis toxin-induced histamine sensitization in rats.
Vleeming W; Hendriksen CF; van de Kuil A; van den Hout JW; de Wildt DJ
Br J Pharmacol; 2000 Apr; 129(8):1801-7. PubMed ID: 10780989
[TBL] [Abstract][Full Text] [Related]
39. Antigenic heterogeneity in subunit S1 of pertussis toxin.
Perera VY; Wardlaw AC; Freer JH
J Gen Microbiol; 1986 Feb; 132(2):553-6. PubMed ID: 2872269
[TBL] [Abstract][Full Text] [Related]
40. Correlation between pertussis toxin IgG antibodies in postvaccination sera and subsequent protection against pertussis.
Taranger J; Trollfors B; Lagergård T; Sundh V; Bryla DA; Schneerson R; Robbins JB
J Infect Dis; 2000 Mar; 181(3):1010-3. PubMed ID: 10720524
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
